POLR2A and colorectal carcinoma: As a control for our in silico analysis, we validated in gastrointestinal cancer cell lines the interaction between SMYD3 and RPB1 (POLR2A), which was previously described by Hamamoto and colleagues in the HCT-116 CRC cell line [13].